Literature DB >> 12626688

GUGULIPID: a natural cholesterol-lowering agent.

Nancy L Urizar1, David D Moore.   

Abstract

The resin of the Commiphora mukul tree has been used in Ayurvedic medicine for more than 2000 years to treat a variety of ailments. Studies in both animal models and humans have shown that this resin, termed gum guggul, can decrease elevated lipid levels. The stereoisomers E- and Z-guggulsterone have been identified as the active agents in this resin. Recent studies have shown that these compounds are antagonist ligands for the bile acid receptor farnesoid X receptor (FXR), which is an important regulator of cholesterol homeostasis. It is likely that this effect accounts for the hypolipidemic activity of these phytosteroids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12626688     DOI: 10.1146/annurev.nutr.23.011702.073102

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  47 in total

1.  Prevention of endotoxin-induced uveitis in rats by plant sterol guggulsterone.

Authors:  Nilesh M Kalariya; Mohammad Shoeb; Aramati B M Reddy; Min Zhang; Frederik J G M van Kuijk; Kota V Ramana
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-30       Impact factor: 4.799

2.  Rational selection of structurally diverse natural product scaffolds with favorable ADME properties for drug discovery.

Authors:  D S Samiulla; V V Vaidyanathan; P C Arun; G Balan; M Blaze; S Bondre; G Chandrasekhar; A Gadakh; R Kumar; G Kharvi; H O Kim; S Kumar; J A Malikayil; M Moger; M K Mone; P Nagarjuna; C Ogbu; D Pendhalkar; A V S Raja Rao; G Venkateshwar Rao; V K Sarma; S Shaik; G V R Sharma; S Singh; C Sreedhar; R Sonawane; U Timmanna; L W Hardy
Journal:  Mol Divers       Date:  2005       Impact factor: 2.943

3.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

4.  Hypolipidemic agent Z-guggulsterone: metabolism interplays with induction of carboxylesterase and bile salt export pump.

Authors:  Dongfang Yang; Jian Yang; Deshi Shi; Da Xiao; Yi-Tzai Chen; Chris Black; Ruitang Deng; Bingfang Yan
Journal:  J Lipid Res       Date:  2012-01-14       Impact factor: 5.922

5.  Identification of trisubstituted-pyrazol carboxamide analogs as novel and potent antagonists of farnesoid X receptor.

Authors:  Donna D Yu; Wenwei Lin; Barry M Forman; Taosheng Chen
Journal:  Bioorg Med Chem       Date:  2014-04-16       Impact factor: 3.641

6.  Guggulsterone inhibits tumor cell proliferation, induces S-phase arrest, and promotes apoptosis through activation of c-Jun N-terminal kinase, suppression of Akt pathway, and downregulation of antiapoptotic gene products.

Authors:  Shishir Shishodia; Gautam Sethi; Kwang Seok Ahn; Bharat B Aggarwal
Journal:  Biochem Pharmacol       Date:  2007-03-30       Impact factor: 5.858

7.  Growth inhibition of struvite crystals in the presence of herbal extract Commiphora wightii.

Authors:  C K Chauhan; M J Joshi; A D B Vaidya
Journal:  J Mater Sci Mater Med       Date:  2008-06-21       Impact factor: 3.896

8.  Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.

Authors:  Rebecca J Leeman-Neill; Sarah E Wheeler; Shivendra V Singh; Sufi M Thomas; Raja R Seethala; Daniel B Neill; Mary C Panahandeh; Eun-Ryeong Hahm; Sonali C Joyce; Malabika Sen; Quan Cai; Maria L Freilino; Changyou Li; Daniel E Johnson; Jennifer R Grandis
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

9.  Inhibition of farnesoid X receptor controls esophageal cancer cell growth in vitro and in nude mouse xenografts.

Authors:  Baoxiang Guan; Hao Li; Zhengduo Yang; Ashraful Hoque; Xiaochun Xu
Journal:  Cancer       Date:  2012-12-20       Impact factor: 6.860

10.  Development of time resolved fluorescence resonance energy transfer-based assay for FXR antagonist discovery.

Authors:  Donna D Yu; Wenwei Lin; Taosheng Chen; Barry M Forman
Journal:  Bioorg Med Chem       Date:  2013-05-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.